The independent source for health policy research, polling, and news.
341 - 360 of 1,570 Results
An epic battle is playing out behind the scenes over whether the government should pay for Aduhelm, an FDA-approved Alzheimerâs drug that scientists say has not been proven to work.
Among the 764 hospitals hit with a 1% reduction in Medicare payments this year for having high numbers of patient infections and avoidable complications are more than three dozen that Medicare also ranks as among the best in the country.
If federal officials accept a courtâs decision, some patients will get a chance to seek refunds for their nursing home and other expenses.
Temporary subsidies helped boost enrollment under the Affordable Care Act to a record 14.5 million, according to the Department of Health and Human Services. But unless Democrats in Congress extend those subsidies, many of those new enrollees will be in for a rude surprise just ahead of midterm elections. Meanwhile, the need to replace retiring Supreme Court Justice Stephen Breyer further crowds an already tight legislative schedule. Joanne Kenen of Politico and the Johns Hopkins Bloomberg School of Public Health, Sarah Karlin-Smith of the Pink Sheet, and Anna Edney of Bloomberg News join KHNâs Julie Rovner to discuss these issues and more. Also this week, Rovner interviews Diana Greene Foster, author of âThe Turnaway Study: Ten Years, a Thousand Women, and the Consequences of Having â Or Being Denied â An Abortion.â
KHN gives readers a chance to comment on a recent batch of stories.
The laws governing Medicare donât provide coverage for self-administered diagnostic tests, which is precisely what the rapid antigen tests are and why they are an important tool for containing the pandemic.
The Supreme Court temporarily blocked a federal rule requiring larger businesses to mandate employees be vaccinated or wear masks and undergo weekly testing. At the same time, however, it allowed a federal order that health care workers be vaccinated.
Medicare officials tentatively plan to restrict the use of a controversial Alzheimerâs drug to only those patients participating in clinical trials, while the Department of Health and Human Services looks into lowering the monthly Medicare Part B premium. Meanwhile, covid confusion still reigns, as the Biden administration moves, belatedly, to make more masks and tests available. Joanne Kenen of Politico and the Johns Hopkins Bloomberg School of Public Health, Sarah Karlin-Smith of the Pink Sheet and Rachel Cohrs of Stat join KHNâs Julie Rovner to discuss these issues and more.
Sen. Joe Manchin (D-W.Va.) dealt a blow to congressional efforts to pass President Joe Bidenâs domestic agenda bill, forcing Democrats to regroup starting in 2022. Meanwhile, the omicron covid variant spreads rapidly in the U.S., threatening the stability of the nationâs health care system. Joanne Kenen of Politico and the Johns Hopkins School of Public Health, Rachel Cohrs of Stat and Sarah Karlin-Smith of the Pink Sheet join KHNâs Julie Rovner to discuss these issues and more, plus a look back at the year in health policy. Also this week, Rovner interviews Ceci Connolly, president and CEO of the Alliance of Community Health Plans.
In West Virginia, older residents often go without dental care, and a quarter of people 65 and older have no natural teeth, the highest rate of any state in the country. But a powerful senator from West Virginia, Joe Manchin, has rebuffed efforts to add a dental benefit to Medicare.
The fight over covid vaccines continues to intensify, with Republicans on Capitol Hill pushing â with some success â to cancel President Joe Bidenâs âtest regularly or vaccinateâ requirement for private employers. Meanwhile, abortion is not the only health issue before the Supreme Court this term. Joanne Kenen of Politico and the Johns Hopkins Bloomberg School of Public Health, Sarah Karlin-Smith of the Pink Sheet and Rachel Cohrs of Stat News join KHNâs Julie Rovner to discuss these issues and more.
Medicare billing codes for audio-only follow-up check-ins lead to new reimbursement battles.
KHN gives readers a chance to comment on a recent batch of stories.
The Community Oncology Alliance is targeting the prescription drug provisions of the Build Back Better Act, saying they will trigger deep cuts in oncologistsâ pay, causing clinics to close and health care costs to rise. But it leaves out some important details.
The Republican senator says President Joe Bidenâs âinflation crisisâ caused Medicare to raise monthly premiums, which will add hundreds of dollars to beneficiariesâ costs. But Medicare experts say inflation was not to blame and most beneficiaries will shoulder a much smaller increase than what Rick Scott claims.
Federal health officials appear poised to extend a recommendation for covid boosters to all adults, following moves by some governors and mayors to broaden the eligible booster pool as caseloads rise. Meanwhile, the Food and Drug Administration finally has a nominee to head the agency: former FDA chief Robert Califf. And Medicare premiums for consumers will likely rise substantially in 2022, partly due to the approval of a controversial drug to treat Alzheimerâs disease. Tami Luhby of CNN, Sarah Karlin-Smith of the Pink Sheet and Rachel Cohrs of Stat join KHNâs Julie Rovner to discuss these issues and more. Also this week, Rovner interviews Dan Weissmann, host of the âAn Arm and a Legâ podcast.
KHN and California Healthline staff made the rounds on national and local media this week to discuss their stories. Hereâs a collection of their appearances.
Congress is making slow progress toward completing its ambitious social spending bill, although its Thanksgiving deadline looks optimistic. Meanwhile, a new survey finds the average cost of an employer-provided family plan has risen to more than $22,000. Thatâs about the cost of a new Toyota Corolla. Alice Miranda Ollstein of Politico, Anna Edney of Bloomberg News and Rebecca Adams of CQ Roll Call join KHNâs Julie Rovner to discuss these issues and more. Also this week, Rovner interviews Rebecca Love, a nurse academic and entrepreneur, about the impending crisis in nursing.
Some insurers pocketed âeye-poppingâ overpayments, billing records show.
Medicare officials say complaints are rising from seniors lured into private plans with misleading information or enrolled without their consent. In response, officials have threatened to penalize the private companies selling Medicare Advantage and drug plans if they or agents working on their behalf mislead consumers.
© 2026 KFF